BX Swiss TOP 30 CHF
1.384,70
PKT
+20,72
PKT
+1,52
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Roche Equal Weight | Barclays Capital | |
| 08.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 04.04.24 | Richemont Buy | Jefferies & Company Inc. | |
| 04.04.24 | UBS Outperform | RBC Capital Markets | |
| 03.04.24 | Swiss Re Sell | UBS AG | |
| 03.04.24 | Givaudan Sell | UBS AG | |
| 03.04.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Givaudan Underweight | Barclays Capital | |
| 02.04.24 | Richemont Overweight | Barclays Capital | |
| 02.04.24 | Richemont Buy | UBS AG | |
| 02.04.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 02.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 28.03.24 | Richemont Buy | Jefferies & Company Inc. | |
| 28.03.24 | UBS Outperform | RBC Capital Markets | |
| 28.03.24 | Richemont Sector Perform | RBC Capital Markets | |
| 28.03.24 | Novartis Underweight | Barclays Capital | |
| 27.03.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 27.03.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 26.03.24 | Nestlé Buy | Deutsche Bank AG | |
| 26.03.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 25.03.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.03.24 | UBS Outperform | RBC Capital Markets | |
| 22.03.24 | Roche Sell | Deutsche Bank AG | |
| 22.03.24 | Novartis Buy | Deutsche Bank AG | |
| 22.03.24 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.24 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 21.03.24 | Nestlé Buy | UBS AG | |
| 21.03.24 | Roche Sell | Deutsche Bank AG | |
| 20.03.24 | Givaudan Underweight | Barclays Capital |